Frank Torti

Frank Torti, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Roivant Sciences Ltd. and Immunovant, Inc. We count 22 filings; the first trade dates from 15 May 2020 and the latest from 30 September 2026.

In open-market terms, that means 1 purchase worth €118k on one side and 3 sales worth €69.6M on the other. Taken together, the sales exceed the purchases by €69.5M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 13 share grants and 3 option exercises. 2026 to date brings no purchases and 3 sales.

The record was last updated on 2 October 2026 with a share grant (€1.3M) in Roivant Sciences Ltd. The most recent open-market purchase was published on 29 September 2022, 1,501 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.